The obestatin/ghrelin system as a novel regulatory mechanism of iris muscle contraction

Current Eye Research

Volumn 33, Issue 1, 2008, Pages 73-79

  Rocha Sousa, A ^a,b   Falcao Reis F ^a   Leite Moreira, A F ^a  

^a University of Porto   (Portugal)

^b Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

Ghrelin; Iris dilator muscle; Iris sphincter muscle; Obestatin; Peptide hormones

Indexed keywords

ADRENALIN; CARBACHOL; GHRELIN; OBESTATIN;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; SPHINCTER; SPHINCTER PUPILLAE MUSCLE;

ANIMALS; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EPINEPHRINE; GHRELIN; IRIS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RABBITS;

EID: 38549101041     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701791058     Document Type: Article

References (31)

1. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005;310:996-999.
2. McKee KK, Tan CP, Palyha OC, et al. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics. 1997;46:426-434.
3. Jackson VR, Nothacker HP, Civelli O. GPR39 receptor expression in the mouse brain. Neuroreport. 2006;17:813-816.
4. Dun SL, Brailoiu GC, Brailoiu E, Yang J, Chang JK, Dun NJ. Distribution and biological activity of obestatin in the rat. J Endocrinol. 2006;191:481-489.
5. Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun. 2006;351:21-25.
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
7. Rocha-Sousa A, Saraiva J, Henriques-Coelho T, Falcao-Reis F, Correia-Pinto J, Leite-Moreira AF. Ghrelin as a novel locally produced relaxing peptide of the iris sphincter and dilator muscles. Exp Eye Res. 2006;83:1179-1187.
8. Leite-Moreira AF, Rocha-Sousa A, Henriques-Coelho T. Cardiac, skeletal and smooth muscle regulation by ghrelin Vitamins & Hormones. 2007;77:208-238.
9. Bedendi I, Alloatti G, Marcantoni A, et al. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol. 2003;476:87-95.
10. Soares JB, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Leite-Moreira AF. Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides. 2006;27:1616-1623.
11. Kleinz MJ, Maguire JJ, Skepper JN, Davenport AP. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res. 2006;69:227-235.
12. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: Ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol. 2002;136:1146-1152.
13. Dass NB, Munonyara M, Bassil AK, et al. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neurosci. 2003;120:443-453.
14. Depoortere I, De Winter B, Thijs T, De Man J, Pelckmans P, Peeters T. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol. 2005;515:160-168.
15. Lagaud GJ, Young A, Acena A, Morton MF, Barrett TD, Shankley NP. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun. 2007;357:264-269.
16. Moechars D, Depoortere I, Moreaux B, et al. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterol. 2006;131:1131-1141.
17. Gourcerol G, St-Pierre DH, Tache Y. Lack of obestatin effects on food intake: Should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept. 2007;141:1-7.
18. Camina JP, Campos JF, Caminos JE, Dieguez C, Casanueva FF. Obestatin-mediated proliferation of human retinal pigment epithelial cells: Regulatory mechanisms. J Cell Physiol. 2007;211:1-9.
19. Tachado SD, Akhtar RA, Abdel-Latif AA. Activation of beta-adrenergic receptors causes stimulation of cyclic AMP, inhibition of inositol trisphosphate, and relaxation of bovine iris sphincter smooth muscle. Biochemical and functional interactions between the cyclic AMP and calcium signaling systems. Invest Ophthalmol Vis Sci. 1989;30:2232-2239.
20. Tachado SD, Akhtar RA, Zhou CJ, Abdel-Latif AA. Effects of isoproterenol and forskolin on carbachol- and fluoroaluminate-induced polyphosphoinositide hydrolysis, inositol trisphosphate production, and contraction in bovine iris sphincter smooth muscle: Interaction between cAMP and IP3 second messenger systems. Cellular Signaling. 1992;4:61-75.
21. Ding KH, Abdel-Latif AA. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles. Invest Ophthalmol Vis Sci. 1997;38:2629-2638.
22. Yoshitomi T, Yamaji K, Ishikawa H, Ohnishi Y. Effect of pituitary adenylate cyclase-activating peptide on isolated rabbit iris sphincter and dilator muscles. Invest Ophthalmol Vis Sci. 2002;43:780-783.
23. Yamaji K, Yoshitomi T, Usui S. Effect of somatostatin and galanin on isolated rabbit iris sphincter and dilator muscles. Exper Eye Res. 2003;77:609-614.
24. Gustafsson LE, Wiklund NP. Adenosine-modulation of cholinergic and non-adrenergic non-cholinergic neurotransmission in the rabbit iris sphincter. Br J Pharmacol. 1986;88:197-204.
25. Hayashi K, Masuda K. Effects of vasoactive intestinal polypeptide (VIP) and cyclic-AMP on the isolated sphincter pupillae muscles of the albino rabbit. Japanese J Ophthalmol. 1982;26:437-442.
26. Marathe GK, Yousufzai SY, Abdel-Latif AA. Mediation by prostaglandins of the stimulatory effect of substance P on cyclic AMP production in dog iris sphincter smooth muscle. Biochem Pharmacol. 1996;52:1261-1269.
27. Yousufzai SY, Ali N, Abdel-Latif AA. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle. Invest Ophthalmol Vis Sci. 1999;40:3245-3253.
28. Pianka P, Oron Y, Lazar M, Geyer O. Nonadrenergic, noncholinergic relaxation of bovine iris sphincter: Role of endogenous nitric oxide. Invest Ophthalmol Vis Sci. 2000;41:880-886.
29. Piccone M, Littzi J, Krupin T, Stone RA, Davis M, Wax MB. Effects of neuropeptide Y on the isolated rabbit iris dilator muscle. Invest Ophthalmol Vis Sci. 1988;29:330-332.
30. Ueda N, Muramatsu I, Sakakibara Y, Fujiwara M. Noncholinergic, nonadrenergic contraction and substance P in rabbit iris sphincter muscle. Japanese J Pharmacol. 1981;31:1071-1079.
31. Gourcerol G, Tache Y. Obestatin - A ghrelin-associated peptide that does not hold its promise to suppress food intake and motility. Neurogastroenterol Motil. 2007;19:161-165.